Acceptability of a New Paediatric Formulation of Hydroxycarbamide in Children With Sickle Cell Disease.
Clinical trial NCT05470270 · COMPLETED
Trial details
- NCT number
- NCT05470270
- Sponsor
- Theravia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-08
- Primary completion
- 2022-10-28
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.